Planning a Clinical Development Programme for Medicinal Products for Irritable Bowel Syndrome: An Analysis of the European Medicines Agency’s Recommendations

E. A. Gerasimets; N. A. Rumyantsev; R. S. Ilin; D. V. Goryachev

Regulatory Research and Medicine Evaluation
Regulyatornye issledovaniya i ekspertiza lekarstvennykh sredstv

ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)

User

eng | рус

Regulatory Research and Medicine Evaluation

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Gerasimets E.A., Rumyantsev N.A., Ilin R.S., Goryachev D.V. Planning a Clinical Development Programme for Medicinal Products for Irritable Bowel Syndrome: An Analysis of the European Medicines Agency’s Recommendations. Regulatory Research and Medicine Evaluation. 2024;14(4):463-473. (In Russ.) https://doi.org/10.30895/1991-2919-2024-14-4-463-473

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Regulatory Research and Medicine Evaluation

For citations:

Cookies policy